Hubbard on assignment at FDA
This article was originally published in The Tan Sheet
Former FDA associate commissioner Bill Hubbard, an oft-quoted critic of the agency, leaves his advising position at the advocacy group Alliance for a Stronger FDA to return to FDA temporarily. In a May 27 e-mail, Hubbard said he is working in the Office of the Commissioner to help the new leadership in "getting things going." As for the regulatory areas or issues he is addressing, Hubbard said his duties are not limited
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.